Topiramate

NDC 70710-1042 · Zydus Pharmaceuticals USA Inc.

Generic nameTopiramate

Dosage formCAPSULE, EXTENDED RELEASE

RouteORAL

Active ingredient(s)TOPIRAMATE

Strength150 mg/1

Pharmacologic classCytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]

Marketing categoryANDA

Packages

70710-1042-3 — 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70710-1042-3)

70710-1042-9 — 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70710-1042-9)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

70518-2391 — Topiramate, 70518-2419 — Topiramate, 70518-2517 — Topiramate, 70518-2955 — Topiramate, 70518-4247 — topiramate, 70518-4340 — Topiramate, 70518-4515 — topiramate, 70710-1039 — Topiramate, 70710-1040 — Topiramate, 70710-1041 — Topiramate, 70710-1043 — Topiramate, 70748-275 — Topiramate, 70748-276 — Topiramate, 70748-277 — Topiramate, 70748-278 — Topiramate, 70771-1315 — Topiramate, 70771-1316 — Topiramate, 70771-1317 — Topiramate, 70771-1656 — Topiramate, 70771-1657 — Topiramate, +289 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels